Dr. Cowan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
550 16th Street
San Francisco, CA 94143Phone+1 415-476-2188Fax+1 415-502-4867
Education & Training
University of California (San Francisco)Residency, Pediatrics, 1976 - 1978
Duke University HospitalResidency, Surgery, 1970 - 1972
Perelman School of Medicine at the University of PennsylvaniaClass of 1970
Certifications & Licensure
CA State Medical License 1975 - 2027- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease Start of enrollment: 2005 Apr 01
- Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders Start of enrollment: 2005 Jan 01
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission Start of enrollment: 2000 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 160 citationsImmune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.Jennifer Heimall, Brent R. Logan, Morton J. Cowan, Luigi D. Notarangelo, Linda M. Griffith
Blood. 2017-12-21 - 179 citationsAssociation of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort a...Imke H. Bartelink, Arief Lalmohamed, Elisabeth M L van Reij, Christopher C. Dvorak, Rada M. Savic
The Lancet. Haematology. 2016-11-01 - 370 citationsNewborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United StatesAntonia Kwan, Roshini S. Abraham, Robert Currier, Amy Brower, Karen Andruszewski
JAMA. 2014-08-20
Journal Articles
- Allograft and Patient Survival After Sequential HSCT and Kidney Transplantation from the Same Donor– a Multicenter AnalysisMorton J Cowan, Tepsiri Chongkrairatanakul, American journal of transplantation
Abstracts/Posters
- Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing P...Morton J Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined ImmunodeficiencyMorton J Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell TransplantsMorton J Cowan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Other
- T cell negative, B cell negative, NK cell positive severe combined immunodeficiencyCowan MJ
http://www.uptodate.com/contents/t-cell-negative-b-cell-negative-nk-cell-positive-severe-combined-im
UpToDate, Wolters Kluwer Health - 2012-10-12
Press Mentions
Study Finds HIV-Containing Gene Therapy Restores Immunity in "Bubble Baby" DiseaseMay 12th, 2021
UCSF Participates in Experimental Therapy Trial for Infants with Rare Genetic Disease SCIDApril 30th, 2019
Docs Use HIV, Gene Remedy to Treatment Bubble Boy IllnessApril 21st, 2019- Join now to see all
Grant Support
- Primary Immune Deficiency Treatment Consortium Annual Scientific MeetingNational Institute Of Allergy And Infectious Diseases2011–2012
- Primary Immune Deficiency Treatment Consortium Administrative UnitNational Institute Of Allergy And Infectious Diseases2011
- Clinical Sites ConsortiumsNational Institute Of Allergy And Infectious Diseases2011
- Primary Immune Deficiency Treatment ConsortiumNational Institute Of Allergy And Infectious Diseases2009–2011
- ID Of DNA PK Dependent Kinase Sites Of Phosphorylation On Artemis ProteinNational Center For Research Resources2004–2005
- Bone Marrow Stem Cell Transplantation For ChildrenNational Center For Research Resources2004–2005
- Tolerance Post In Utero TransplantationNational Heart, Lung, And Blood Institute1998–2005
- Busulfan Pharmacokinetics In Patients Undergoing Bone Marrow TransplantationNational Center For Research Resources2000–2002
- Gene Linkage Study Of Immunodeficiency In Navajo IndiansNational Institute Of Allergy And Infectious Diseases1993–2001
- Tolerance Induction In Utero Renal TransplantationNational Center For Research Resources1997
- Rhesus Model Of In Utero Stem Cell TransplantationNational Center For Research Resources1996
- Recruitment Of Hematopoietic Stem Cells W/ Stem Cell Factor &G CSFNational Center For Research Resources1996
- Induction Of Tolerance In Marrow TransplantationNational Institute Of Allergy And Infectious Diseases1990–1994
- HIV Infection In Children Of IV Drug Abusing WomenNational Institute On Drug Abuse1990–1992
- AIDS Associated Retrovirus (ARV) Infection In ChildrenNational Institute On Drug Abuse1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
